The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFG.L Regulatory News (PFG)

  • There is currently no data for PFG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Provident Financial plc

27 Mar 2019 10:44

RNS Number : 1767U
JPMorgan Securities Plc
27 March 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Provident Financial plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Joint Financial Adviser and Corporate Broker to Provident Financial PLC

(d) Date dealing undertaken:

26 March 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Non-Standard Finance plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Share

 

 

Purchase

 

Sale

58,108

 

33,224

5.1780 GBP

 

5.1794 GBP

5.0874 GBP

 

5.1180 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

Equity Swap

Long

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

363

3,106

6,709

543

1,993

4,239

394

 

488

1,001

4,521

513

172

1,345

1,005

487

2,900

5.1216 GBP

5.1218 GBP

5.1220 GBP

5.1330 GBP

5.1401 GBP

5.1457 GBP

5.1760 GBP

 

5.0995 GBP

5.1140 GBP

5.1232 GBP

5.1260 GBP

5.1282 GBP

5.1284 GBP

5.1341 GBP

5.1344 GBP

5.1365 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

27 March 2019

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERPGUPCWUPBGUM
Date   Source Headline
17th Feb 202010:36 amRNSFCA Final Notice of Moneybarn Investigation
7th Feb 20203:40 pmRNSHolding(s) in Company
31st Jan 20204:30 pmRNSTotal Voting Rights
27th Jan 20204:22 pmRNSHolding(s) in Company
24th Jan 20208:25 amRNSHolding(s) in Company
15th Jan 20209:26 amRNSBlock listing Interim Review
15th Jan 20207:00 amRNSTrading Update
9th Jan 20204:47 pmRNSHolding(s) in Company
9th Jan 20204:42 pmRNSHolding(s) in Company
31st Dec 201912:45 pmRNSTotal Voting Rights
23rd Dec 201912:31 pmRNSHolding(s) in Company
17th Dec 20192:54 pmRNSHolding(s) in Company
10th Dec 20194:46 pmRNSHolding(s) in Company
9th Dec 20197:00 amRNSDirectorate Change
29th Nov 20194:30 pmRNSTotal Voting Rights
29th Nov 20193:24 pmRNSDirector Declaration
12th Nov 20198:39 amRNSHolding(s) in Company
7th Nov 20194:41 pmRNSHolding(s) in Company
7th Nov 20199:36 amRNSHolding(s) in Company
7th Nov 20197:00 amRNS3rd Quarter Trading & Capital Markets Day Update
31st Oct 20194:42 pmRNSTotal Voting Rights
24th Oct 20198:32 amRNSHolding(s) in Company
17th Oct 20193:44 pmRNSHolding(s) in Company
15th Oct 20192:53 pmRNSHolding(s) in Company
14th Oct 20192:59 pmRNSHolding(s) in Company
11th Oct 20191:28 pmRNSHolding(s) in Company
8th Oct 20193:28 pmRNSDirector/PDMR Shareholding
1st Oct 20192:27 pmRNSHolding(s) in Company
30th Sep 20194:30 pmRNSTotal Voting Rights
27th Sep 20192:40 pmRNSHolding(s) in Company
27th Sep 20198:32 amRNSDirector Declaration
23rd Sep 20193:53 pmRNSHolding(s) in Company
17th Sep 20192:17 pmRNSHolding(s) in Company
11th Sep 20191:55 pmRNSHolding(s) in Company
6th Sep 20193:45 pmRNSHolding(s) in Company
6th Sep 20193:45 pmRNSHolding(s) in Company
30th Aug 20194:30 pmRNSTotal Voting Rights
9th Aug 20195:10 pmRNSDirector/PDMR Shareholding
8th Aug 20192:00 pmRNSHolding(s) in Company
2nd Aug 20191:31 pmRNSHolding(s) in Company
2nd Aug 20199:15 amRNSHolding(s) in Company
1st Aug 20192:31 pmRNSHolding(s) in Company
31st Jul 20194:31 pmRNSTotal Voting Rights
31st Jul 20194:29 pmRNSDirector/PDMR Shareholding
30th Jul 20197:00 amRNSDirectorate Change - Simon Thomas
30th Jul 20197:00 amRNSInterim Results for Six Months ended 30 June
29th Jul 20198:54 amRNSHolding(s) in Company
26th Jul 20199:00 amRNSHolding(s) in Company
15th Jul 20194:30 pmRNSBlock listing Interim Review
9th Jul 201911:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.